Phase I study of Debio1143 (AT406) in combination with daunorubicin (D) and cytarabine (C) in patients with poor-risk acute myeloid leukemia (AML) Meeting Abstract
| Authors: | DiPersio, J. F.; Erba, H. P.; Larson, R. A.; Luger, S. M.; Mangan, K. F.; Tallman, M. S.; Brill, J. M.; Vuagniaux, G.; Rouits, E.; Zanna, C.; Sorensen, J. M. |
| Abstract Title: | Phase I study of Debio1143 (AT406) in combination with daunorubicin (D) and cytarabine (C) in patients with poor-risk acute myeloid leukemia (AML) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203847 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.7029 |
| Notes: | Meeting Abstract: 7029 -- Source: Wos |
